$0.0551
At close: Feb 20, 3:18 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Nanopharmaceutics in recent months.
Browse guidance and forecast on all stocks.